Lilly's marketing approach and its pipeline of medications

Status
Not open for further replies.
Grogu said:
Eli Lilly Isn't Replacing Zepbound -- It's Building an Obesity Empire - AOL

And it's not too late to get in on the action.

www.aol.com

Rather than canalbilizing tirzepatide sales, management appears to be telling investors that retatrutide will be marketed to the more obese and metabolically challenged patients as to differeniate the product in the market. That should be interesting conversations at doctors offices.

Patient: Hey doc, I hear that there is this great new drug on the market and that I'll lose a ton of weight

Doc: Yeah, but you're not fat enough

Patient: Should I gain some weight

Doc: No, just use the less effective medication

Nine months later.....

Patient: Hey doc, I didn't lose enough, can I try that new drug?

Doc: Oh no, we have an adjunct called eloralintide that would be much better to add to the tirzepatide. Now you have to pay for two scripts.
I was just having a conversation with a friend today about peptides. I got cut off from Zepbound by the Great Insurance Ban Hammer in January. Hence, my eventual intro to the grey market. Even if they turned around and said they'd cover it again, I prefer getting my own, buying it myself for essentially pennies per mg, and controlling my own dosage. And honestly, I think its better than Lilly's. Well, I can honestly only speak on Reta - my Tirz came from ProRX when I did the compounded route. But I thought it hit harder than Eli's.

Once I got over the nervousness of drawing up my own dose and pinning myself - its been easy breazy. I love having control over this aspect of my health journey, and I feel fucking great.
 
I strongly suspect they will position retatrutide as their top line drug for severe obesity and maybe for its effects on reducing liver fat, and they will price it higher than tirzepatide to distinguish it in the market. From what I have read there will be increasing price pressure on GLP's to get cheaper, so maybe they will price it more like tirz is now and drop the price on tirz. No matter how they market it , doctors are going to choose the more effective drug in the end, the only real control the drug companies have is through advertising and pricing. As reta will be the most effective drug on the market charging extra for it seems very likely.
 
Thee Oohwee said:
And honestly, I think its better than Lilly's. Well, I can honestly only speak on Reta - my Tirz came from ProRX when I did the compounded route. But I thought it hit harder than Eli's.
Zepbound would be my choice hands down over grey tirz for not worrying about endotoxins, sterility, unknown excipients, and now salts. You could always get a higher dose of Zepbound.
 
I'm thinking Orforglipron for maintenance and low level weight loss. Tirz marketed for moderate weight loss. Tirz plus Eloralintide for next step up. Retatrutide top end. Personally I want to try low dose Eloralintide and Reta for maintenance, but EL is not testing that combination.
 
m100568 said:
I'm thinking Orforglipron for maintenance and low level weight loss. Tirz marketed for moderate weight loss. Tirz plus Eloralintide for next step up. Retatrutide top end. Personally I want to try low dose Eloralintide and Reta for maintenance, but EL is not testing that combination.
Same here
 
Status
Not open for further replies.

Trending content

Members online

No members online now.

Forum statistics

Threads
2,419
Messages
51,228
Members
1
Latest member
Admin
Back
Top